|
Laxman Pai, Opalesque Asia: Amid declining Q1 M&A volumes in Europe following uncertainty surrounding the COVID-19 outbreak, UK scores highest number of deals with 610, said a study.
According to GlobalData, the European region witnessed consistent decline in mergers and acquisition (M&A) deal volume during Q1 2020, decreasing from 710 in January, to 699 in February, and to 599 in March 2020.
Deal value also started declining near the end of the quarter, registering growth from US$25.4bn in January to US$49.1bn in February before declining to US$27.5bn in March, said the data and analytics company.
Aurojyoti Bose, Lead Analyst at GlobalData said: "The decline in M&A volume and value could be attributed to uncertainty surrounding the COVID-19 outbreak. In volume terms, the top five countries (the UK, Germany, France, Sweden, and Italy) accounted for around 62% of total deal volume, whereas the top five countries (France, the Netherlands, the UK, Germany, and Italy) by value accounted for around 73% of total deal value."
All top five countries by value except the Netherlands showcased decline in deal value in March 2020 compared to February 2020.
Bose added: "Although in terms of value, the Netherlands witnessed growth in March 2020, this was only due to the announcement of one high-value deal, excluding which deal value also declined in this country."
The acquisition announcement of Qiagen by Thermo Fisher Scientific for US$11.5bn in March 2020 raised the ...................... To view our full article Click here
|
RSS
